| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac …
Over the last 12 months, insiders at HeartSciences Inc. have bought $0 and sold $0 worth of HeartSciences Inc. stock.
On average, over the past 5 years, insiders at HeartSciences Inc. have bought $0 and sold $15,621 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| Increased Positions | 5 | +50% | 32,917 | +18.79% |
| Decreased Positions | 2 | -20% | 10,291 | -5.87% |
| New Positions | <1 | New | 5,968 | New |
| Sold Out Positions | 2 | Sold Out | 10,291 | Sold Out |
| Total Postitions | 13 | +30% | 197,849 | +12.91% |